Witte Jan De's most recent trade in Resmed Inc. was a trade of 2,000 ReMed Common Stock done at an average price of $243.5 . Disclosure was reported to the exchange on May 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ResMed | Witte Jan De | Director | Sale of securities on an exchange or to another person at price $ 243.47 per share. | 20 May 2025 | 2,000 | 5,806 (0%) | 0% | 243.5 | 486,940 | ReMed Common Stock |
| ResMed | Witte Jan De | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2024 | 1,083 | 7,806 (0%) | 0% | 0 | ReMed Common Stock | |
| ResMed | Witte Jan De | Director | Sale of securities on an exchange or to another person at price $ 248.81 per share. | 12 Nov 2024 | 796 | 6,723 (0%) | 0% | 248.8 | 198,053 | ReMed Common Stock |
| ResMed | Witte Jan De | Director | Sale of securities on an exchange or to another person at price $ 218.29 per share. | 15 May 2024 | 360 | 7,519 (0%) | 0% | 218.3 | 78,584 | ReMed Common Stock |
| ResMed | Witte Jan De | Director | Sale of securities on an exchange or to another person at price $ 218.29 per share. | 15 May 2024 | 360 | 7,519 (0%) | 0% | 218.3 | 78,584 | ReMed Common Stock |
| ResMed | Witte Jan De | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2023 | 1,768 | 7,879 (0%) | 0% | 0 | ReMed Common Stock | |
| ResMed | Witte Jan De | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2022 | 1,122 | 6,111 (0%) | 0% | 0 | ReMed Common Stock | |
| ResMed | Witte Jan De | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2021 | 956 | 4,989 (0%) | 0% | 0 | ResMed Common Stock | |
| ResMed | Witte Jan De | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 259.47 per share. | 11 Nov 2021 | 104 | 4,033 (0%) | 0% | 259.5 | 26,985 | ReMed Common Stock |
| ResMed | Witte Jan De | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.11 per share. | 27 Nov 2020 | 183 | 4,137 (0%) | 0% | 212.1 | 38,816 | ReMed Common Stock |
| ResMed | Witte Jan De | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2020 | 1,187 | 4,320 (0%) | 0% | 0 | ReMed Common Stock |